Detection of Coronary Artery Disease Using Analysis of High Frequency QRS: The HyperQ Registry
NCT ID: NCT01325467
Last Updated: 2012-03-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
900 participants
OBSERVATIONAL
2011-05-31
2012-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Feasibility of High Frequency QRS Analysis in Patients With Acute Myocardial Infarction
NCT01150825
Comparison of the HyperQ Versus Conventional Electrocardiogram (ECG) to Detect Ischemia
NCT00917800
Assessment of HyperQ Signal for Detecting Ischemia During Dobutamine Stress ECG
NCT00310622
Hyperpolarized MRSI in Ischemic Heart Disease: A Metabolic Investigation of the Heart Muscle
NCT06054516
ECG Methods for the Prompt Identification of Coronary Events
NCT04237688
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Referred for exercise MPI due to suspected coronary artery disease
Exclusion Criteria
* Pre-excitation syndrome
* QRS duration \> 120 ms
* Atrial Fibrillation or significant ventricular arrhythmia
* Treatment with Digoxin
* Pacemaker with 100% pacemaker dependence
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
BSP Biological Signal Processing Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jamieson M Bourque, MD
Role: PRINCIPAL_INVESTIGATOR
University of Virginia Health System
Robert Schwartz, MD
Role: PRINCIPAL_INVESTIGATOR
Minneapolis Heart Institute Foundation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Minneapolis Heart Institute Foundation
Minneapolis, Minnesota, United States
Cleveland Clinic Foundation
Cleveland, Ohio, United States
University of Virginia
Charlottesville, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Clin_05_01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.